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Summary As experimental models for breast cancer, most studies rely on established human breast cancer cell lines. However, many of
these lines were established over 20 years ago, many from pleural effusions rather than the primary tumour, so the validity of using them as
representative models is questionable. This paper describes our experiences, over a 3-year period, in establishing short-term epithelial-cell-
enriched preparations from primary breast tumours based on differential centrifugation followed by culture in selective media. Epithelial cells
were successfully cultured from 55% of samples, but culture success did not appear to be correlated with tumour histology, stage, grade or
node status. Epithelial cell-enriched cultures were immunopositive for broad-spectrum cytokeratin and epithelial membrane antigen (EMA).
Positivity for keratin 19 confirmed that the cultures contained tumour-derived cells, which additionally showed significantly higher activity of
the reductive pathway of the steroid-converting enzyme 17p-hydroxysteroid dehydrogenase type 1. That the cultures contained tumour and
not normal epithelial cells was further substantiated by the complete absence of the calmodulin-like gene NB-1 in tumour-derived cultures;
this is only associated with normal breast epithelia. Eighty-five per cent of cultures established from oestrogen receptor (ER)-positive tumours
expressed ER in vitro; this was functional in 66% of cultures, although ER-positive phenotype was gradually lost over time. In conclusion,
epithelial cells can be isolated and maintained as short-term cultures from primary breast tumours irrespective of histopathological or clinical
details, providing a model system with a greater biological and clinical relevance than breast cancer cell lines.
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The majority of scientists and clinicians involved with breast
cancer research use established breast cancer cell lines for in vitro
studies, and a significant amount of useful information has been
accumulated from these over the years. However, little considera-
tion is given to the fact that many ofthese cell lines were originally
described over 20 years ago and, with genetic drift, may bear very
little resemblance to the primary tumour from which they were
derived. This point is reinforced by the observation that conflicting
results have often been reported from different laboratories in
identical studies using the 'same' target cell (Osborne et al, 1987).
Further, the most used in vitro model for breast cancer, the MCF-7
cell line, first described in 1973 (Soule et al, 1973), was actually
derived from an aggressive metastatic pleural effusion, as is the
case with most ofthe breast cancer cell lines currently in use today
(Cailleau et al, 1974). Despite this, a database search of the litera-
ture over the past three decades using Medline (Win SPIRS version
2.0 on Silverplatter) and Bath Information Database Service
(BIDS), revealed thatthe MCF-7 cell line still remains the model of
choice as aresearch tool, with 97% ofthe published literature using
this as a model for breast cancer and less than 3% of published
studies using primary cultures derived from breast tumours.
The reasons for the continued use ofcell lines as in vitro models
are obvious, the prime one being their ease of use. Cell lines are
well characterized homogeneous populations that (usually) give
consistent andreproducible results from experiment to experiment.
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They are also easily replaced if lost through contamination. Many
of these lines express functional oestrogen and/or progesterone
receptors and some have been characterized at the genetic level.
Nevertheless, it has been a long-standing target of many laborato-
ries to establish and maintain primary cultures, particularly of
luminal epithelial cells, from which most breast cancers arise
(Taylor-Papadimitrou et al, 1989), as a more representative in vitro
model. However, these experiments have met with limited success,
mainly because breast cancer epithelial cells can be difficult to
establish, with slow doubling times. Furthermore, such cultures are
often poorly characterized, with rapid overgrowth by fibroblasts
frequently representing a considerable technical challenge.
The aim ofthis study was to establish a reproducible technique
suitable for the short-term culture of human breast epithelial cells
derived from breast tumours to provide sufficient quantities of
cells for molecular and cell biology studies. Using a modification
of a method based on differential centrifugation followed by
culture in selective media (Emerson and Wilkinson, 1990; Speirs
et al, 1996a), this report describes our experiences in establishing
such cultures over a 3-yearperiod and discusses theirbenefits over
cell lines. The cultures have been characterized by a number of
criteria including immunocytochemistry and flow cytometry with
a range ofprimary antibodies, RT-PCR to detect the NB-] gene, a
calmodulin-like protein of unknown function that is expressed in
cultured normal, but not malignant, mammary epithelial cells
(Yaswen et al, 1990; 1992; Stampfer and Yaswen, 1993) and the
presence of increased reductive activity of the steroid-converting
enzyme 17p-hydroxysteroid dehydrogenase type I (17-HSD),
which is significantly up-regulated in breast tumours (Vermeulen
et al, 1986; Peltoketo et al, 1996).
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Table 1 Pathoclinical details of breast tumours used in this study
Clinical parameter Numbers
Patients
Total number in study 109
Age (years)
Mean 63
Range 32-90
Tumour histology
Duct origin 88
Lobule origin 14
Miscellaneousa 7
Tumour grade
15
11 41
III 46
Not known 7
Lymph node status
Positive 58
Negative 48
Not known 3
Tumour stage
Ti 25
T2 73
T3 5
T4 1
Not known 5
aThis group comprised one apocrine, one leiomyosarcoma, two medullary,
two mixed lobular-ductal carcinoma and one tumour of ductal-mucoid origin.
METHODS
Tissue samples
Breast tumours were obtained from 109 patients undergoing
surgery for the removal of a clinically confirmed breast lesion who
presented sequentially. The mean age was 63 years (range 32-90).
Clinicopathological details ofthe tumours are presented in Table 1.
Cell isolation and culture
Upon receipt, tissue was washed extensively in phosphate-buffered
saline (PBS) supplemented with 200 U of penicillin, 200 gg ml-1
streptomycin and 5 ,ug ml-' fungizone (all Life Technologies,
Paisley, UK), then minced finely and disaggregated for 18-20
in 0.1% collagenase type III (Life Technologies) as previously
described (Speirs et al, 1996b). Digested tissue was removed from
the incubator and shaken vigorously by hand to disaggregate any
remaining large clumps. Three cell populations were then isolated
using differential centrifugation (Emerson and Wilkinson, 1990).
This is described in greater detail in the results section and illus-
trated schematically in Figure 1. For the first 24 h, cells from the
organoid and epithelial fractions were plated in 75% organoid
medium (OM) and 25% Dulbecco's modified Eagle medium
(DMEM) containing 10% heat-inactivated fetal bovine serum
(HIFBS) to promote cell attachment. OM consisted of DMEM
supplemented with 100 U ml-' penicillin, 100 ,ug ml-' strepto-
mycin, 2 mm glutamine, 10 mm Hepes, 0.075% bovine serum
albumin (BSA), 10 ng ml-' cholera toxin (ICN Biomedicals, Oxon,
UK), 0.5 gg ml-' hydrocortisone, 5 gg ml-' insulin and 5 ng ml-1
epidermal growth factor (EGF) (all Sigma, Poole). The pH was 7.4.
After 24 h media was removed and replaced with OM. Cells were
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Figure 1 Schematic illustration of the cell separation procedure with
representative phase contrast micrographs of the isolated cell fractions after
7 days in culture. Scale bar = 15 pim
maintained in this for the duration ofthe culture. Stromal cells were
seeded in DMEM containing glutamine, penicillin, streptomycin
and 10% HIFBS and maintained in this throughout.
Cell characterization
Immunostaining
To confirm the phenotypic identity of the isolated cells, immuno-
staining was carried out. Cultures were fixed with absolute
methanol for 10 min at room temperature and immunostained using
a Vectastain Quick kit (Vector Laboratories, Peterborough, UK).
Fibroblasts were detected with vimentin (1:100; Sigma), whereas
epithelial cells were detected with broad-spectrum cytokeratin
(clone MNF1 16; 1:100; Dako, High Wycombe, UK), keratin 19
(K19, 1:100; Dako) and epithelial membrane antigen (EMA; 1:40;
Dako). To detect ER-a, epithelial cultures were immunostained
with ER antibody 1D5 (directed against the A/B domain of ER;
Dako) purchased as an optimally prediluted solution, according to
the manufacturer's instructions. Methanol-fixed cultures ofthe ER-
positive breast carcinoma cell line, MCF-7, served as a positive
control. As a negative control, cultures were incubated with
negative control reagent provided with the primary antibody. This
consisted offetal calfserum in 0.05 M Tris-HCl, pH 7.6, containing
carrier protein and 15 mm sodium azide. To determine if ER status
in cell cultures correlated with that of the primary tumour from
which they were derived, formalin-fixed paraffin-embedded
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sections from breast tumours were also immunostained. Sections A
were dewaxed, rehydrated and, before immunostaining, sections
were subjected to microwave enhancement as previously recom-
mended for detection of ER (Sannino and Shousa, 1994). Positive
immunostaining was detected using the ABC method (Hsu et al,
1981) with diaminobenzidine as a substrate.
.. ...... ~~~~~Flow cytometry
Flow cytometry analysis (FACS) was carried out on representative
* ~~~epithelial (n =8) and stromal (n =10) cultures. Cells were
detached from the culture vessel by treatment with PBS/0.1%
EDTA at 37°C, then incubated for 30 min at room temperature
with antibodies against CALLA (which detects myoepithelial
cells; O'Hare et al, 1991) or EMA. This was followed by a further
30 min incubation with FITC-conjugated secondary antibody
(Becton Dickinson). For each sample a total of 10 000 cells were
analysed (FACSCalibur, Becton Dickinson). Gates were set such
that the negative control contained only 5% positive cells.
RT-PCR
Total RNA was extracted from 23 tumour-derived epithelial
cultures, 17 epithelial cultures derived from reduction mammo-
plasties, the breast cancer cell lines MCF-7 and BT-20 and the
osteosarcoma cell line Saos2, and reverse transcribed to cDNA as
....-........... previously described (Speirs et al, 1995). This was amplified with
oligonucleotide primers designed to detect NB-I, a calmodulin-
related gene expressed by most normal but not by malignant
mammary epithelial cells (Yaswen et al, 1990; 1992; Stampfer and
Yaswen, 1993). Primer sequences were as follows:
5'-TGT TTG ACA AGG ATG GGG AC-3'
B 5'-CAC ACG GAC AAA CTC CTC GT-3'
01 . E cDNA was amplified in a thermal cycler (Hybaid OmniGene;
lb ~~~~~~~~~~~~ ~~annealing temperature 550C as previously described; Speirs et al,
IF. 5 e;* 810 *;0 1996a). Primers were designed to span introns so that signals from
Aw >dEf .. mRNA could be distinguished from any contaminating genomic I $B,'g i i w >i<J ^: DNA. To check for cDNA integrity, a fragment of the constitu-
tively expressed glyceraldehyde phosphate dehydrogenase
Al , o :g1* <;(GAPdH) gene was amplified and a reaction where sterile distilled
_1* water substituted for cDNA acted as a negative control. Product
identity was confirmed by restriction mapping. An aliquot of 5 ,ul
of PCR product was incubated with BanI restriction enzyme (New
England Biolabs) for 2 h at 37°C, which yielded two discrete frag-
, ments of 252 and 128 bp. Cleaved and uncleaved products were
separated on a 2% agarose gel and visualized by ethidium bromide
'''" _F e staining under UV illumination.
.44e Determination of cell number and viability
P _ g Direct cell counting andviability was performed on three cultures,
as in general there were insufficient cells per tissue sample to
(_-; ,sacrifice for cell counting only. To promote cell attachment, _ 4 epithelial cells were plated at 2x104 cells per well in 24-well plates _: * - in 75% OM, 25% DMEM containing 10% HIFBS for 24 h before
W tt_ \t' s # transferring to OM for the remainder oftheexperiment. Cells were
counted every 5-6 days over a 21-day period with weekly media
changes. Viability was determined by trypan blue exclusion.
..... Measurement of 17p-hydroxysteroid dehydrogenase
(17-HSD) Figure 2 Eleven-day breast epithelial cultures.A K19-positive colony adjacent to cells that are Kl 9 negative. (B) Focal positivity for EMA. Scale Primaryepithelial cultures derived from breast tumours (n = I1) and bars= 20 gm (A), 15jIm (B) normal breast (reduction mammoplasties; n = 10) were established
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Figure 3 Expression of EMA but not CALLA on 9-day breast tumour
epithelial cells by FACS analysis. Peak a, irrelevant control antibody; peak b,
EMA; peak c, CALLA. Fifty-two % of cells were positive for EMA
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Figure 4 Growth of breast cancer epithelial cells in vitro. Cells were seeded
in 24-well plates and triplicate wells counted on days 6, 10, 15 and 21 post
seeding. Each data point represents the mean of three wells ± s.e.;-U Bcal;
i, Bca2; * BCa3
in six-well plates and allowed to reach 70% confluence. Oxidative
and reductive 17-HSD type I activities were determined by
measuring the ability ofintact cell monolayers to convert reversibly
exogenous [3H]EI to [3H]E2 (Speirs et al, 1993). Cells were
incubated with 2 nm ofeither3[H]E1 (reductive pathway) or [3H]E2
(oxidative pathway; both Amersham) in serum-free medium for 4 h
at 37°C. Blanks were run in parallel. Following incubation, the
medium was removed and added to glass tubes containing
5000 d.p.m. of either l4[C]E2 (reductive pathway) or [14]CEl
(oxidative pathway; both Amersham) as a recovery label. Steroids
were extracted with 4 ml ofdiethyl ether, evaporated to dryness and
separated by thin-layer chromatography using a solvent system of
dichloromethane-ethyl acetate (4:1). Product and recovery radio-
activity were determined by liquid scintillation counting. Results
were expressed as fmol of product mg-' protein 4h-'. Total protein
was assessed by the BioRad protein assay (BioRad). All samples
were assayed in duplicate.
b d e f g h
Figure 5 Representative agarose gel showing expression of NB-1
transcripts (380 bp; top) and the constitutively expressed GAPdH (326 bp;
bottom). Top, lanes a, c, d and f show positive products for NB-1 obtained
from 7-day cultures of normal breast epithelial cells. Age-matched tumour-
derived cultures were negative (lanes b and e). Lane g, negative control; lane
h, restriction mapped product giving fragments of 252 and 128 bp after
digestion with Banl. Bottom, lanes a-f show positive GAPdH products for
each sample. Lane g, negative control; lane h, restriction mapped product
giving fragments of 228, 52 and 46 bp after digestion with HinI. Note that the
two small fragments migrated ahead of the dye front and are not visible on
the photograph. L, 100 bp ladder (top and bottom)
Statistical analysis
The chi-squared test was used to determine statistical significances
for cell culture criteria and the unpaired Student's t-test was used
for 17-HSD experiments.
RESULTS
Criteria used to ascertain culture success
Epithelial cultures were considered to be successful if they
displayed the following features: (1) attachment and growth of
phenotypically epithelial-like cells to the culture vessel after 3-5
days in vitro in defined medium; (2) continued growth, underthese
conditions, for up to 6-8 weeks with a doubling time of approxi-
mately 3-6 days, with no evidence of fibroblastic infiltration;
(3) immunopositivity for broad-spectrum cytokeratin, clonal reac-
tivity for K19 and EMA, with no expression of vimentin or
CALLA; (4) lack ofexpression of the NB-I gene by RT-PCR; (5)
preferential reductive 17-HSD activity in cell monolayers. These
characteristics are described in greater detail below.
Phenotypic identity
The differential centrifugation technique gave rise to cell popula-
tions from all three centrifugal fractions (Figure 1). The organoid
fraction consisted predominantly of small fragments of partially
digested tissue from which epithelial-like cells began to grow after
1-2 days in organoid medium. Epithelial cell-enriched cell pellets
were obtained by recentrifuging the supernatant at higher speed,
yielding mainly single cells, which, when cultured in organoid
medium, displayed a characteristic cobblestone morphology
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Figure 6 Reductive (E1l-E2) and oxidative (E2-E1) 17-HSD activity in
11-day epithelial cells derived from breast tumours (BCa) and normal breast
(RM). *P < 0.05 vs respective RM, **P < 0.05 vs respective BCa. Each bar
represents the mean of triplicate experiments ± s.e.
indicative ofepithelial cells. The epithelial supernatant was recen-
trifuged to yield stromal cells, which had a typical spindle-shaped
morphology and formed parallel arrays upon reaching confluence,
a feature typical of fibroblasts. Confirmation of the phenotypic
identity of the three populations was validated by immunostaining
with specific primary antibodies and has previously been
published (Speirs et al, 1996a). Focal positivity for K19, which is
associated with luminal epithelial cells, and EMA, an epithelial
cell-surface marker, was observed in some organoid and the
majority of epithelial fractions, but absent from the stromal frac-
tion (Figure 2).
FACS analysis
To complement the immunostaining, FACS analysis was carried
out using specific cell-surface antigens. As predicted, approxi-
mately 50% ofepithelial cells expressed EMA with no expression
ofthe myoepithelial marker CALLA (Figure 3).
Cell growth
As illustrated in Figure 4, growth rates of epithelial cells derived
from different tumours varied, with population doubling times
between 3 and 6 days. After 21 days, cells began to reach plateau.
Cell viability was assessed by trypan blue exclusion and ranged
from 99% when the cultures were first established to 85% after 21
days in vitro. Cultures described in this paper were not routinely
continued beyond 21 days, although in a previous study we have
shown similar cultures to be both phenotypically and genotypi-
cally stable in vitro for up to 6-8 weeks (Speirs et al, 1996a).
Genetic analysis
Breast cDNA was amplified with primers designed to detect frag-
ments corresponding to the NB-I gene. In 13/17 breast epithelial
cultures derived from reduction mammoplasties, RT-PCR revealed
a single band of 380 bp that corresponded to the predicted size of
the NB-] cDNA transcript, the identity of which was confirmed by
restriction mapping (Figure 5). This transcript was not detected in
23 tumour-derived primary epithelial cultures or in tumour-derived
Table 2 Histological tumour types which yielded successful cultures
Tumour histology Epithelial growth (%) P-value
Ductal (n = 88) 49 (56) 1.0a
Lobular (n = 14) 8 (57)
Miscellaneous (n = 7) 3 (43)
aDuctal vs lobular.
Table 3 Culture success in relation to tumour grade
Tumour grade Epithelial growth (%) Pvalue
8 (53) 1.ia
11 24 (59) 0.93b
lI l l24 (52) 1.oc
Not known 4 (57)
aGrade vs grades 11 and l1l. bGrade 11 vs grades and 11. cGrade IlIl vs grades
and 11.
Table 4 Culture success in relation to patient age
Decade Number of samples Epithelial growth (%)
3rd 2 0
4th 16 13 (81)
5th 26 15 (58)
6th 27 16 (59)
7th 29 10 (34)
8th 8 5 (62)
9th 1 1 (100)
Table 5 Oestrogen receptor status in tumour tissue and cultured cells and
its relationship with tumour growth
Tumour ER status Epithelial growth (%) Pvalue
Positive (n = 21) 15 (71) 1.0a
Negative (n = 15) 10 (67)
aER positive vs ER negative.
cell lines of breast (MCF-7, BT-20) or bone (Saos2) origin,
although transcripts for the constitutively expressed GAPdH gene
were expressed by such cultures, indicating the integrity of the
cDNA used for PCR amplification.
Activity of 17p-hydroxysteroid dehydrogenase type I in
normal and malignant breast epithelial cultures
Reductive (El-*E2) and oxidative (E2-4E1) activities for epithe-
lial culture derived from normal breast and breast tumours are
illustrated in Figure 6. In tumour-derived cultures, the reductive
pathway was preferred; this was significantly greater than reduc-
tive activity associated with epithelial cells derived from normal
breast. For the oxidative pathway, the reverse was true with this
pathway superior in cultures derived from normal rather than
malignant breast.
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Figure 8 Effect of 17f-oestradiol on proliferation of 5-day epithelial cultures
derived from human breast tumours. *P < 0.05 vs untreated control. Each bar
represents the mean of triplicate experiments s.e.C, BCal;*, BCa2;1,
BCa3
B
_S - Correlation of culture success with clinical details
To ascertain if tumours that yielded successful cultures were asso-
:ciated with a particular clinical feature, culture statistics were
... ~~~~~~~~correlated with clinical details. Tumourhistology did not appear to
be an important factor in establishing viable epithelial cultures,
with cultures equally likely to be established from tumours of
} X _ ... ductal or lobular origin (Table 2). Similarly, tumour grade had no
bearing on culture success (Table 3). Correlating this with patient
age, epithelial growth appeared to be more likely from tumours
taken from patients in the fourth to sixth decades (Table 4).
Tumour stage or lymph node status were both unimportant in
terms of successful epithelial cell growth (data not shown). A
notable feature was that the number of successful cultures we
established increased over the 3 years since the initiation of the
study, giving a mean success rate of 55%, suggesting that culture
success is due to technical expertise rather than a specific clinical
feature.
C
Correlating tissue ER with cell culture ER status
ER data was available for 36 breast tumours. Of these, 21
expressed ER by immunohistochemistry. This is summarized in
Table 5. Primary cultures were established from seven tumours
~~~~~~~~~~~~known to be ER positive to determine if ER phenotype was main-
. tained in vitro. Six out of seven cultured samples (at passage 0)
4.. # . 1 _ t D _stained positively for nuclear ER by immunocytochemistry. This is
illustrated in Figure 7. Addition of exogenous 17p-oestradiol to
these cultures resulted in a growth stimulation of up to twofold by
approximately two-thirds of all cultures, confirming the function-
ality of the receptor (Figure 8). However, ER expression was lost
after two or three passages, indicating that the receptor is not
phenotypically stable in these cultures (data not shown).
....... ....... DISCUSSION
This study has described the successful short-term culture and
phenotypic characterization of breast cancer epithelial cells derived
ire 7 Immunostaining for ER (A) 7-day primary breast epithelial culture, from primary human tumours. Routine primary culture of epithelial MCF-7 positive control, (C) MCF-7 negative control. In A and B strong
ear staining is evident (arrows). No staining is evident in C. Scale bars cells derived from such tumours has been a goal of many laboratories
,ml (A) and 20gm (B and C) and the cultures described herein have proved highly suitable for a
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variety of cell and molecular biology studies (Speirs et al, 1996a;
Green et al, 1997). These cultures retain many of the characteristics
associated with breast tumours in vivo, particularly the presence of
functional ER and a high level of reductive 17-HSD, an enzyme
involved in steroid biosynthesis whose activity is up-regulated in
breast tumours (Vermeulen et al, 1986; Peltoketo et al, 1996).
Epithelial cell-enriched preparations were isolated using a
differential centrifugation method. This technique gave rise to
three individual fractions, termed organoid, epithelial and stromal,
all of which have previously been characterized (Speirs et al,
1996a). The organoid fraction was heterogeneous, consisting of
small pieces of partially digested tissue and single cells. For this
reason and as it had been reported that tumour organoids give rise
to rapidly proliferating epithelial cells, the majority of which are
genetically normal (Wolman et al, 1985), we chose not to use this
fraction as a source of epithelial cells. The epithelial fraction was
characterized using two different immunological methods. By
immunohistochemistry, the epithelial nature of the cultures was
confirmed; this revealed positivity for broad-spectrum cytokeratin
and focal positivity for EMA. Further characterization by FACS
analysis of specific surface antigens showed EMA positivity on
about 50% of epithelial cells. As predicted, there was no evidence
for CALLA, a myoepithelial cell marker (O'Hare et al, 1991), in
these cells.
ER was detected in 85% of cultured breast epithelial cells
isolated from ER-positive tumours. Its functionality was
confirmed by a growth response to exogenous 17p-oestradiol in
approximately two-thirds of these cultures. However, the receptor
was not phenotypically stable with a gradual loss of expression
over time. Loss of ER in vitro has previously been reported in
breast (Pink et al, 1996) and osteosarcoma (Nasir and Speirs,
1997) cell lines and has been attributed to oestrogen deprivation in
culture. Although we do not routinely add E2 to the organoid
medium used to maintain our epithelial cultures, in a small number
of cases we supplemented the medium added to the longer term
cultures (i.e. those that had undergone at least two passages) with
E2 but were still unable to detect ER (unpublished observations).
This suggests that loss of ER by these cultures is an irreversible
process. Using normal breast as a model, it has recently been
suggested that ER-positive cells do not generally proliferate, but
rather act as sensor cells for circulating E2, whereas the prolifer-
ating cells act as effecter cells in terms of oestrogen-stimulated
mitogenesis (Clarke et al, 1997). As such, proliferation of ER-
negative cells may be controlled by paracrine factors released from
ER-positive cells under the influence of oestradiol; this may be
disrupted in breast tumours (Clarke et al, 1997).
Basic immunohistochemistry and FACS analysis confirmed the
phenotypic nature of the epithelial fraction; however, one of the
major stumbling blocks in this type ofwork is knowing whether or
not the isolated cells are of neoplastic origin, because breast
tumours contain cells of normal as well as malignant origin
(Petersen et al, 1990). Therefore, epithelial cultures were addition-
ally stained with K19, which is universally expressed in breast
tumours (Bartek et al, 1985). Although this antigen is expressed in
tissue sections by luminal epithelial cells within the terminal
ductal lobular units ofboth normal and malignant origin, in vitro it
is generally only associated with tumour epithelial cells (Taylor-
Papadimitrou et al, 1989) and as such has been used as a marker to
detect lymph node micrometastases in breast cancer patients
(Schoenfield et al, 1994; 1996). In accordance with other studies,
isolated epithelial cells were not universally positive for K19;
instead, K19 positivity was restricted to single cells or islands of
cells adjacent to colonies that were K19 negative (Shearer et al,
1992; Bergstraesser and Weitzman, 1993; Ethier et al, 1993). It has
been reported that fetal bovine serum (FBS) is required to maintain
a K19-positive phenotype (Ethier et al, 1993). In the present study,
cells were exposed to FBS (final concentration 2.5%) for the first
24 h before transferring into organoid medium, which contained
BSA rather than FBS (we substituted BSA for FBS to inhibit over-
growth with fibroblasts). This appeared to be sufficient to maintain
the K19 phenotype, at least for the duration of our experiments,
although it would be interesting to establish the long-term effects
of BSA on K19 expression in vitro.
To further confirm the phenotype of our epithelial cultures we
carried out RT-PCR studies on the NB-] gene. This encodes a
calmodulin-like protein ofunknown function (Yaswen et al, 1990).
In normal breast epithelial cultures, the gene was detectable in
13/17 instances, but not found in either tumour-derived epithelial
cultures or in tumour cell lines derived from breast or bone. This
concurs with other studies that have shown its expression in
cultured normal, but not malignant, mammary epithelial cells
(Yaswen et al, 1990; 1992; Stampfer and Yaswen, 1993). It has
also been suggested that in normal breast, the gene is down-regu-
lated in vitro (Yaswen et al, 1990), which may explain the lack of
expression of NB-1 in four normal epithelial cultures. The sensi-
tivity of the PCR, in theory capable of amplifying message from a
single cell, unequivocally demonstrates that our cultures contained
tumour and not normal epithelial cells. If contaminating normal
epithelial cells were present in our tumour cell preparations, these
would have certainly been detected by RT-PCR for the NB-I gene,
particularly after 35 amplification cycles.
Our biochemical results provided further evidence that our
cultures contained malignant cells because, in cell cultures derived
from tumours, the reductive pathway of 17-HSD type I was signifi-
cantly greater than the oxidative direction. This is in agreement
with a number of previous studies that showed this to be the
preferred direction in breast tumours (Adams et al, 1988a; Reed et
al, 1991; Poutanen et al, 1995; Castgnetta et al, 1996). In contrast,
in cultures derived from normal breast, the oxidative pathway was
preferred. Differences in enzyme direction between cell cultures
from normal and tumorous breast may reflect the ratio of endoge-
nous co-factor activity associated with each tissue type that will
drive the reaction in a particular direction. Although co-factors are
routinely used when measuring 17-HSD activity in soluble tissue
fractions, we deliberately did not add them to our cell cultures as
addition ofthese factors may have influenced the enzyme direction.
Recently, Dairkee et al (1997) have described a method based
on a partial enzymatic degradation of tumour stroma that permits
enrichment and expansion of breast epithelial cells in vitro.
Although their technique differs from the one described herein,
both methods give rise to similar proportions of epithelial cells
with proliferative capacity (Dairkee, 66%, this study, 55%).
However, with Dairkee's method, contamination of the epithelial
fraction with fibroblasts was apparent, requiring differential tryp-
inization to remove them. With our method, a combination of
differential centrifugation followed by culture in medium designed
to encourage epithelial proliferation, fibroblast overgrowth was
not a problem. Although we have previously optimized our tumour
dispersal technique to give superior cell yields without compro-
mising viability (Speirs et al, 1996b), perhaps a combination ofthe
partial enzymatic digestion (Dairkee et al, 1997), followed by the
differential centrifugation method would prove a more appropriate
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choice to maximize yields of breast cancer epithelial cells for
future studies.
It is important to note that when this study was initiated, it was
not our objective to establish a method to support the long-term
culture of primary breast cancer epithelial cells or to establish a
new cell line(s). Breast tumours, by their nature, contain hetero-
geneous mixtures of cells and extended culture would tend, by
natural selection, to favour cells with a more robust phenotype.
Phenotypic changes in response to culture conditions have been
reported (Taylor-Papadimitrou et al, 1989) and it is quite likely
that genotypic aberrations may be induced with long-term culture.
Over the years, new cell lines have been established from only a
very small percentage of primary tumours (1-2%; Petersen et al,
1990; Band et al, 1990; Meltzer et al, 1991). However, a more
recent report has described the long-term culture ofapproximately
7% of cultures established from primary breast cancers, nearly all
of which went on to form new cell lines (McCallum and Lowther,
1996). Interestingly, the majority of these cultures grew in suspen-
sion, in contrast to most other studies, and were more likely to be
established from grade III tumours with a steroid receptor-nega-
tive phenotype (McCallum and Lowther, 1996). However, in our
study, pathoclinical features including tumour histology, grade,
stage or node status had no bearing on culture success. Indeed the
most notable feature of this study was the increased proportion of
viable cultures established over time, which we attribute to tech-
nical expertise rather than aparticular clinical characteristic. There
also appeared to be a trend for cultures to be established from
tumours taken from individuals in the fourth to sixth decades.
However, as the majority ofour samples came from this age group
(71/109) this is unlikely to be a significant observation, particu-
larly as cultures were readily established from tumours removed
from more elderly patients as well. Thus, age is probably not an
important factor in determining culture success.
In accord with many other groups, we were unable to culture
breast epithelial cells that were universally positive for the luminal
epithelial marker K19. However, breast tumours in vivo do not
consist entirely of tumour cells, but contain a heterogeneous
mixture comprising normal/benign epithelial cells and stromal
cells as well as cells of the immune system. It has been proposed
that, in vivo, tumour epithelial cells may have an absolute depen-
dence on paracrine signals from neighbouring cells (Lippmann
et al, 1989; Osborne and Arteaga, 1990). This is reinforced by in
vitro studies that showed paracrine factors secreted by breast
tumour-derived fibroblasts or lymphocytes stimulated prolifera-
tion of breast cancer cell lines (Adams et al, 1988b; van
Roozendaal et al, 1992) and primary cultures of breast cancer
epithelial (Ogmundsdottir et al, 1993; Hofland et al, 1995;
Emerman et al, 1996). Thus, paracrine-autocrine interactions are
likely to be important factors in determining the biological behav-
iour of a tumour. Furthermore, a culture system such as ours may
give a far more accurate representation of the tumour in situ than
studies with isolated, homogeneous, cell types. Additionally, the
ability to culture stromal cells independently from epithelial cells
offers the possibility of recombination experiments, allowing the
recreation, under controlled conditions, of cell interactions that
clearly exist in vivo. These interactions should be given consider-
ation in determining the response of a tumour to drug therapy, as
they may influence the manner in which the tumour responds.
The value of a reproducible method for primary culture of
breast cancer epithelial cells is significant. In the pharmaceutical
industry the use of cell cultures derived from human primary
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material has enormous potential in the hunt for novel therapeutics.
Further, there are considerable ethical pressures on scientists to
seek alternatives to animals for drug discovery and the use of
primary cell cultures could circumvent the need for these types of
experiments. Another area where this technique may prove valu-
able is in predicting patient response to drug therapy. Establishing
cell cultures from a tumour and determining the in vitro response
to, for example anti-oestrogens or chemotherapeutic drugs may
permit specific adjuvant therapies to be tailored to the needs ofthe
individual patient, which, in the long term, may benefit prognosis.
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